Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ·Healthcare·Biotechnology
$3.39
+11.07%
Mkt Cap $59.38M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (17 analysts)
$33.67
Range $33.00 – $35.00
Implied Upside
+893.2%
Consensus $33.67 vs current $3.39